EUVIMEDEUVIMED entdecken
Crossref

Proton pump inhibitor use and appropriateness analysis: a snapshot from a secondary care hospital

Sukaina Salim Damji, Syed Arman Rabbani, Padma G M Rao, Ain-ur Rashid Butt

Journal of Pharmaceutical Health Services Research · 10.05.2021 · 12 (2) · 206-212

DOI: 10.1093/jphsr/rmab013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Health Services Research, online erschienen am 07.04.2021. Verfasst von Sukaina Salim Damji und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Proton pump inhibitors (PPIs) have become one of the most frequently prescribed drugs since their introduction 30 years ago. Effectiveness and safety profile of PPIs has led to their overutilization and has exposed patients to a number of potential risks. The objective of this study was to evaluate the use of PPIs in a secondary care hospital in the United Arab Emirates.

Methods

This prospective observational drug-utilization study was conducted in patients receiving treatment with PPIs and admitted to internal medicine wards of the study site. Electronic patient case records were reviewed and data on PPI prescribing was collected and analysed. Appropriateness of PPI use was assessed as per international guidelines. Key findings Out of 172 patients enrolled, 53.5% were females with median age of 57 years (34.3, 71.0). Four different PPIs were prescribed to study patients, pantoprazole (86.6%), esomeprazole (5.8%), rabeprazole (4.1%) and omeprazole (3.5%). Ninety-two (53.5%) patients were prescribed intravenous PPI, whereas 80 (46.5%) patients were given PPI in oral form. Overall, 103 (59.9%) patients had inappropriate PPI prescriptions. Of these inappropriate prescriptions, 22 patients had no clear indication for PPI use and for 16 patients; PPIs were indicated for stress ulcer prophylaxis in low-risk category. Corticosteroid use [odds ratio (OR): 4.34, 95% confidence interval (CI): 1.22–15.46; P = 0.023] was significantly associated with greater odds of inappropriate PPI use.

Conclusions

We report a high prevalence of inappropriate PPI prescribing among the hospitalized patients in our study. Inappropriate PPI prescribing is a concerning issue and collective efforts should be made to check and minimize the same.

Zitieren

APA

Damji, S. S., Rabbani, S. A., Rao, P. G. M., & Butt, A. R. (2021). Proton pump inhibitor use and appropriateness analysis: a snapshot from a secondary care hospital. Journal of Pharmaceutical Health Services Research, 12(2), 206-212. https://doi.org/10.1093/jphsr/rmab013

Vancouver

Damji SS, Rabbani SA, Rao PGM, Butt AR. Proton pump inhibitor use and appropriateness analysis: a snapshot from a secondary care hospital. Journal of Pharmaceutical Health Services Research. 2021;12(2):206-212. doi:10.1093/jphsr/rmab013

BibTeX
@article{Damji2021,
  author = {Damji, Sukaina Salim and Rabbani, Syed Arman and Rao, Padma G M and Butt, Ain-ur Rashid},
  title = {Proton pump inhibitor use and appropriateness analysis: a snapshot from a secondary care hospital},
  journal = {Journal of Pharmaceutical Health Services Research},
  year = {2021},
  volume = {12},
  number = {2},
  pages = {206--212},
  doi = {10.1093/jphsr/rmab013}
}
Kostenlos starten →